Abstract
We report the first synthesis of the C-terminally spermine-conjugated stapled peptide-based inhibitors of the p53-Mdm2 interaction. Subsequent biological, biophysical and cellular uptake assays with the spermine-conjugated stapled peptides revealed that spermine conjugation minimally affects biological activity while significantly increases peptide helicity and cellular uptake without apparent cytotoxicity.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Sequence
-
Cell Survival / drug effects
-
Cells / drug effects
-
Circular Dichroism
-
Fluorescein / chemistry
-
HeLa Cells
-
Humans
-
Microscopy, Fluorescence
-
Peptides / chemical synthesis
-
Peptides / chemistry*
-
Peptides / pharmacology
-
Proto-Oncogene Proteins c-mdm2 / antagonists & inhibitors*
-
Proto-Oncogene Proteins c-mdm2 / metabolism
-
Spermine / chemistry*
-
Tumor Suppressor Protein p53 / antagonists & inhibitors*
-
Tumor Suppressor Protein p53 / metabolism
Substances
-
Peptides
-
Tumor Suppressor Protein p53
-
Spermine
-
MDM2 protein, human
-
Proto-Oncogene Proteins c-mdm2
-
Fluorescein